Comparison of Depression Interventions After Acute Coronary Syndrome
A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 150 participants.
Also called NCT01032018
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose other
- Phase
- Phase 1/2
- Enrolled
- 150 participants
- Sponsor
- Registry
-
NCT01032018
-
- Main results
- Centralized, stepped, patient preference-based treatment for patients with post-acute coronary syndrome depression: CODIACS vanguard randomized controlled trial
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT01032018. Randomized; single masking; primary purpose other. Start 2010-01 (registry gives no type); primary completion 2012-01 (actual). Results posted on 2014-08-12.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Comparison of Depression Interventions After Acute Coronary Syndrome
- Acronym
- CODIACS
- Condition
- Acute Coronary Syndrome
- Condition
- Depression
- Intervention (Behavioral)
- Problem Solving Therapy
- Intervention (Drug)
- Sertraline, citalopram, or bupropion
- Intervention (Other)
- Standard care
- Lead sponsor
- Columbia University
- Collaborator
- National Heart, Lung, and Blood Institute (NHLBI)
- Collaborator
- University of North Carolina, Chapel Hill
- Collaborator
- Emory University
- Collaborator
- Yale University
- Collaborator
- Washington University School of Medicine
- Collaborator
- University of Pennsylvania
Record details
- Record id
cardio:ct-nct01032018- Content hash
d5c6e7b888496e8bbf341abb9ffe7ac815d18b733bbd22bf5ab96bee03e9909e